Diabetes Renders Photoreceptors Susceptible to Retinal Ischemia-Reperfusion Injury

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2024 Nov 21

PMID 39570639

Authors

David A Antonetti

Cheng-Mao Lin

Sumathi Shanmugam

Heather Hager

Manjing Cao

Xuwen Liu

Alyssa Dreffs

Adam Habash

Steven F Abcouwer

Affiliations

Soon will be listed here.

Abstract

Purpose: Studies have suggested that photoreceptors (PR) are altered by diabetes, contributing to diabetic retinopathy (DR) pathology. Here, we explored the effect of diabetes on retinal ischemic injury.

Methods: Retinal ischemia-reperfusion (IR) injury was caused by elevation of intraocular pressure in 10-week-old BKS db/db type 2 diabetes mellitus (T2DM) mice or C57BL/6J mice at 4 or 12 weeks after streptozotocin (STZ)-induced type 1 diabetes mellitus (T1DM), and respective nondiabetic controls. Retinal neurodegeneration was evaluated by retinal layer thinning, TUNEL staining, and neuron loss. Vascular permeability was evaluated as retinal accumulation of circulating fluorescent albumin. The effects of pretreatment with a sodium-glucose co-transporter (SGLT1/2) inhibitor, phlorizin, were examined.

Results: Nondiabetic control mice exhibited no significant outer retinal layer thinning or PR loss after IR injury. In contrast, db/db mice exhibited significant outer retina thinning (49%, P < 0.0001), loss of PR nuclei (45%, P < 0.05) and inner segment (IS) length decline (45%, P < 0.0001). STZ-induced diabetic mice at 4 weeks showed progressive thinning of the outer retina (55%, by 14 days, P < 0.0001) and 4.3-fold greater number of TUNEL+ cells in the outer nuclear layer (ONL) than injured retinas of control mice (P < 0.0001). After 12 weeks of diabetes, the retinas exhibited similar outer layer thinning and PR loss after IR. Diabetes also delayed restoration of the blood-retinal barrier after IR injury. Phlorizin reduced outer retinal layer thinning from 49% to 3% (P < 0.0001).

Conclusions: Diabetes caused PR to become highly susceptible to IR injury. The ability of phlorizin pretreatment to block outer retinal thinning after IR suggests that the effects of diabetes on PR are readily reversible.

References

Arden G . The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment. Br J Ophthalmol. 2001; 85(3):366-70. PMC: 1723904. DOI: 10.1136/bjo.85.3.366. View

Yen F, Cheng-Chung Wei J, Yu T, Hung Y, Hsu C, Hwu C . Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinopathy in Patients With Type 2 Diabetes. JAMA Netw Open. 2023; 6(12):e2348431. PMC: 10733799. DOI: 10.1001/jamanetworkopen.2023.48431. View

Huang S, Bair P, Chang S, Kao Y, Chen S, Wang I . Risk of Diabetic Retinopathy in Patients With Type 2 Diabetes After SGLT-2 Inhibitors: A Nationwide Population Cohort Study. Clin Pharmacol Ther. 2023; 115(1):95-103. DOI: 10.1002/cpt.3074. View

Datlinger F, Wassermann L, Reumueller A, Hajdu D, Steiner I, Salas M . Assessment of Detailed Photoreceptor Structure and Retinal Sensitivity in Diabetic Macular Ischemia Using Adaptive Optics-OCT and Microperimetry. Invest Ophthalmol Vis Sci. 2021; 62(13):1. PMC: 8496411. DOI: 10.1167/iovs.62.13.1. View

Sayour A, Ruppert M, Olah A, Benke K, Barta B, Zsary E . Effects of SGLT2 Inhibitors beyond Glycemic Control-Focus on Myocardial SGLT1. Int J Mol Sci. 2021; 22(18). PMC: 8468664. DOI: 10.3390/ijms22189852. View

Chung Y, Ha K, Lee K, Kim D . Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study. PLoS One. 2019; 14(10):e0224549. PMC: 6816558. DOI: 10.1371/journal.pone.0224549. View

Zelniker T, Braunwald E . Clinical Benefit of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 75(4):435-447. DOI: 10.1016/j.jacc.2019.11.036. View

Rieg T, Vallon V . Development of SGLT1 and SGLT2 inhibitors. Diabetologia. 2018; 61(10):2079-2086. PMC: 6124499. DOI: 10.1007/s00125-018-4654-7. View

Madrakhimov S, Yang J, Kim J, Han J, Park T . mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy. Cell Commun Signal. 2021; 19(1):29. PMC: 7913405. DOI: 10.1186/s12964-020-00698-4. View

10.

Xu Y, Han F, Tan J . Edaravone protects the retina against ischemia/reperfusion‑induced oxidative injury through the PI3K/Akt/Nrf2 pathway. Mol Med Rep. 2017; 16(6):9210-9216. DOI: 10.3892/mmr.2017.7739. View

11.

Fu Y, Hu T, Zhang Q, Meng S, Lu Y, Xiang A . Transneuronal Degeneration in the Visual Pathway of Rats following Acute Retinal Ischemia/Reperfusion. Dis Markers. 2021; 2021:2629150. PMC: 8670974. DOI: 10.1155/2021/2629150. View

12.

Wiemann S, Yousf A, Joachim S, Peters C, Mueller-Buehl A, Wagner N . Knock-Out of Tenascin-C Ameliorates Ischemia-Induced Rod-Photoreceptor Degeneration and Retinal Dysfunction. Front Neurosci. 2021; 15:642176. PMC: 8172977. DOI: 10.3389/fnins.2021.642176. View

13.

Goncalves A, Dreffs A, Lin C, Sheskey S, Hudson N, Keil J . Vascular Expression of Permeability-Resistant Occludin Mutant Preserves Visual Function in Diabetes. Diabetes. 2021; 70(7):1549-1560. PMC: 8336002. DOI: 10.2337/db20-1220. View

14.

Sternberg Jr P, Landers 3rd M, Wolbarsht M . The negative coincidence of retinitis pigmentosa and proliferative diabetic retinopathy. Am J Ophthalmol. 1984; 97(6):788-9. DOI: 10.1016/0002-9394(84)90518-x. View

15.

Schmid H, Renner M, Dick H, Joachim S . Loss of inner retinal neurons after retinal ischemia in rats. Invest Ophthalmol Vis Sci. 2014; 55(4):2777-87. DOI: 10.1167/iovs.13-13372. View

16.

Eleftheriadou A, Riley D, Zhao S, Austin P, Hernandez G, Lip G . Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database. Diabetologia. 2024; 67(7):1271-1282. PMC: 11153282. DOI: 10.1007/s00125-024-06132-5. View

17.

Zhang C, Gu L, Xie H, Liu Y, Huang P, Zhang J . Glucose transport, transporters and metabolism in diabetic retinopathy. Biochim Biophys Acta Mol Basis Dis. 2023; 1870(3):166995. DOI: 10.1016/j.bbadis.2023.166995. View

18.

Sheskey S, Antonetti D, Renteria R, Lin C . Correlation of Retinal Structure and Visual Function Assessments in Mouse Diabetes Models. Invest Ophthalmol Vis Sci. 2021; 62(10):20. PMC: 8383928. DOI: 10.1167/iovs.62.10.20. View

19.

Li J, Hung Y, Bair H, Hsu S, Hsu C, Lin C . Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study. Sci Rep. 2023; 13(1):17049. PMC: 10564914. DOI: 10.1038/s41598-023-43893-2. View

20.

Liu H, Tang J, Du Y, Saadane A, Samuels I, Veenstra A . Transducin1, Phototransduction and the Development of Early Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2019; 60(5):1538-1546. PMC: 6736377. DOI: 10.1167/iovs.18-26433. View